We are live on ! Find out more
MLAB icon

Mesa Laboratories
MLAB

158 hedge funds and large institutions have $535M invested in Mesa Laboratories in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 56 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

3.24% more ownership

Funds ownership: 91.49% → 94.73% (+3.2%)

3% more funds holding

Funds holding: 154 → 158 (+4)

4% more capital invested

Capital invested by funds: $515M → $535M (+$19.8M)

9% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 56

Holders
158
Holders Change
+4
Holders Change %
+2.6%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
51
Reduced
56
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$27.2M
2
RA
Royce & Associates
New York
+$10.1M
3
BCM
Boone Capital Management
Georgia
+$6.24M
4
CCA
Conestoga Capital Advisors
Pennsylvania
+$4.7M
5
BlackRock
BlackRock
New York
+$3.91M

Top Sellers

1
Principal Financial Group
Principal Financial Group
Iowa
-$12.3M
2
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management
California
-$11M
3
DDC
DF Dent & Co
Maryland
-$5.73M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$3.61M
5
KLC
Kent Lake Capital
Nevada
-$2.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$88.6M +$3.91M +40,138 +5%
CCA
2
Conestoga Capital Advisors
Pennsylvania
$60.6M +$4.7M +48,253 +9%
Morgan Stanley
3
Morgan Stanley
New York
$54.8M +$27.2M +279,295 +115%
Vanguard Group
4
Vanguard Group
Pennsylvania
$38.8M +$709K +7,274 +2%
RA
5
Royce & Associates
New York
$28.3M +$10.1M +103,623 +62%
RIM
6
Ranger Investment Management
Texas
$23.7M +$262K +2,689 +1%
State Street
7
State Street
Massachusetts
$20.8M +$1.45M +14,874 +8%
GCM
8
Geneva Capital Management
Wisconsin
$19.9M -$554K -5,683 -3%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$13.3M -$74.5K -764 -0.6%
EAM
10
Eagle Asset Management
Florida
$12.1M +$321K +3,298 +3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$11.6M +$587K +6,026 +6%
KCM
12
Kennedy Capital Management
Missouri
$11.2M -$237K -2,429 -2%
GT
13
Glenmede Trust
Pennsylvania
$9.52M -$337K -3,454 -4%
Northern Trust
14
Northern Trust
Illinois
$8.54M -$1.3M -13,385 -14%
GIM
15
Granahan Investment Management
Massachusetts
$7.53M +$781K +8,013 +13%
Goldman Sachs
16
Goldman Sachs
New York
$6.93M -$2.05M -21,056 -24%
BCM
17
Boone Capital Management
Georgia
$6.71M +$6.24M +64,064 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$6.4M +$471K +4,835 +9%
Ameriprise
19
Ameriprise
Minnesota
$5.72M +$493K +5,054 +10%
RJA
20
Raymond James & Associates
Florida
$4.93M -$1.99M -20,407 -30%
Comerica Bank
21
Comerica Bank
Texas
$4.77M -$62.1K -637 -1%
Charles Schwab
22
Charles Schwab
California
$4.34M +$87.1K +894 +2%
Bank of America
23
Bank of America
North Carolina
$4.06M -$869K -8,919 -19%
Russell Investments Group
24
Russell Investments Group
United Kingdom
$3.77M -$242K -2,480 -6%
Wells Fargo
25
Wells Fargo
California
$3.74M -$2.8M -28,720 -45%
1
2 3 4 5

MLAB Hedge Fund Activity: Q4 2023 in Review

158 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2023, worth a combined $535M — up 3.8% from $515M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MLAB positions and 20 closed out — a net gain of 6 holders — while 51 added to existing stakes and 56 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $27.2M. The largest seller was Principal Financial Group, cutting an estimated $12.3M.

  • 158 institutional investors held Mesa Laboratories (MLAB) as of Q4 2023, up from 154 in Q3 2023.
  • Funds reported $535M of Mesa Laboratories stock for Q4 2023, up 3.8% quarter-over-quarter.
  • 26 funds opened new Mesa Laboratories positions in Q4 2023 and 20 closed out, a net change of +6 holders.
  • The largest Mesa Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $27.2M added.
  • The largest Mesa Laboratories seller in Q4 2023 was Principal Financial Group, an estimated $12.3M sold.

Based on aggregated 13F filings for Q4 2023.